1 1

Cell Signaling Institute

GHK-Cu: Dermatologic & Regenerative Peptide

GHK-Cu: Dermatologic & Regenerative Peptide

Home / Course / GHK-Cu: Dermatologic & Regenerative Peptide

Copper-Peptide Science for Skin, ECM, and Tissue Recovery

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. Its levels decline with age — correlating with reduced regenerative capacity, impaired wound healing, and diminished tissue resilience.

GHK-Cu occupies a specific clinical niche: topical dermatologic rejuvenation and post-procedure recovery, supported by small but controlled human trials for topical use — making it one of the better-evidenced peptides in the CSI formulary for its primary application.

Evidence Tier: B–C — Tier B (Moderate) for topical use with human pilot studies; Tier C (Emerging) for oral liposomal with preclinical data only.

$199.00 USD
$199.00 USD
Sale Coming Soon
View full details

What You’ll Be Able To Do

  • Describe GHK-Cu’s mechanisms: ECM reconstruction (collagen I/III, elastin, GAGs), inflammation control (NF-κB, TNF-α suppression), and copper biology (lysyl oxidase, SOD, cytochrome c oxidase)
  • Differentiate topical liposomal protocols (Tier B evidence, starter-level) from oral liposomal protocols (Tier C, intermediate complexity)
  • Design topical protocols for photoaging, post-procedure recovery, and scar remodeling with appropriate concentration, timing, and monitoring
  • Screen for copper-specific contraindications: Wilson’s disease, copper allergy, heavy metal overload, and drug interactions
  • Evaluate when to recommend baseline copper panels and long-term monitoring for oral liposomal use

Clinical Focus Areas

Dermatologic Rejuvenation — Skin thinning, elasticity loss, fine lines, and photoaging. 8–12 week topical protocols with controlled trial support (Tier B).

Post-Procedure Recovery — Adjunct to fractional laser, microneedling, and chemical peels. Barrier-compromised skin repair.

Extracellular Matrix Remodeling — Collagen and glycosaminoglycan restoration. Balanced MMP/TIMP modulation for structured remodeling.

Scar Remodeling & Wound Healing — Hypertrophic and atrophic scars (adjunctive). Chronic wound support through fibroblast and keratinocyte activation.

Who This Is For

Clinicians integrating aesthetic medicine, regenerative dermatology, or skin repair into their practice. Relevant for post-procedure protocol development, anti-aging skin programs, and barrier-repair applications.

Prerequisite: CSI Foundations (complimentary)

Course Details

Format: Self-paced, interactive online module via Reach 360

Time to Complete: Approximately 1 hour

Lessons: 7

Price: $199

Includes: Dosing & Protocol Desk Guide, Clinical Decision Tree, Evidence Reference Card, Competency Assessment

Frequently Asked Questions

Does this module cover topical and oral liposomal GHK-Cu?

Yes. Topical liposomal is the primary protocol focus with the strongest evidence base (Tier B). Oral liposomal is addressed as an intermediate-complexity option for systemic tissue support, with clear notation that no human oral bioavailability studies have been published.

Do I need to monitor copper levels?

For topical-only protocols, copper monitoring is generally not required. For oral liposomal — particularly in long-term use — a baseline copper panel is recommended. The module covers copper biology, drug interactions, and monitoring cadence in detail.

Is injectable GHK-Cu covered?

Injectable GHK-Cu is not a supported formulation in this curriculum. It carries an FDA Category 2 designation with no published human safety or efficacy data for the injectable route. The module focuses on topical and oral liposomal pathways only.